These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 32141531)
1. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition. Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-340-5p inhibits the malignant phenotypes of osteosarcoma by directly targeting NRF2 and deactivating the PI3K/AKT pathway. Fan HP; Wang SY; Shi YY; Sun J Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3661-3669. PubMed ID: 34109575 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway. Cong K; Li CG; Wei YH; Zhang K; Xu HB Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway. Chen B; Zheng ZY; Yang JZ; Li XG Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3611-3620. PubMed ID: 31114985 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway. Fu Y; Tang Y; Wang J; Guo Z Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735 [TBL] [Abstract][Full Text] [Related]
6. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition. Chen WY; Xu YY; Zhang XY Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500 [TBL] [Abstract][Full Text] [Related]
7. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Zhang L; Zhao G; Ji S; Yuan Q; Zhou H Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139 [TBL] [Abstract][Full Text] [Related]
8. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway. Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. Jiang HW; Li L; Jiang P; Wang YF Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway. Li YM; Li XJ; Yang HL; Zhang YB; Li JC Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295 [TBL] [Abstract][Full Text] [Related]
11. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5. Ye F; Tian L; Zhou Q; Feng D Gene; 2019 Dec; 721():144093. PubMed ID: 31473323 [TBL] [Abstract][Full Text] [Related]
12. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway. Liang K; Liao L; Liu Q; Ouyang Q; Jia L; Wu G Clin Transl Oncol; 2021 Nov; 23(11):2350-2357. PubMed ID: 34133001 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma. Sun YH; Liu ZF; Yang BB; Yu B Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573 [TBL] [Abstract][Full Text] [Related]
14. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1. Zhang Y; Wang F; Wang L; Zhang Q World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945 [TBL] [Abstract][Full Text] [Related]
15. [microRNA-16-5p targeted tetraspanin 15 gene to inhibit the proliferation, migration and invasion of osteosarcoma cell through phospoinositide 3-kinase/protein kinase B signaling pathway]. Yu JB; Zhang HJ; Yan LW; Chang F; Jia ZW; Yang XR Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1668-1675. PubMed ID: 32486604 [No Abstract] [Full Text] [Related]
16. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1. Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7978-7988. PubMed ID: 31599423 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway. Zhao LW; Yu AJ; Zhang YJ; Wang XC; Han B; Wang XH Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):55-64. PubMed ID: 31957818 [TBL] [Abstract][Full Text] [Related]
18. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2. Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1. Jiang R; Zhang C; Liu G; Gu R; Wu H J Cell Biochem; 2017 Nov; 118(11):3765-3774. PubMed ID: 28379605 [TBL] [Abstract][Full Text] [Related]
20. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2. Chen J; Zhou J; Chen X; Yang B; Wang D; Yang P; He X; Li H Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]